N'-(3-bromo-4-fluorophenyl)-4-morpholin-4-yl-1,2,5-oxadiazole-3-carboximidamide
C13H13BrFN5O2 — CID 70642576
Data last refreshed: (MolForge compound catalog, from PubChem)
About N'-(3-bromo-4-fluorophenyl)-4-morpholin-4-yl-1,2,5-oxadiazole-3-carboximidamide
N'-(3-bromo-4-fluorophenyl)-4-morpholin-4-yl-1,2,5-oxadiazole-3-carboximidamide (PubChem CID 70642576) has the molecular formula C13H13BrFN5O2 and a molecular weight of 370.18 g/mol. Its IUPAC name is N'-(3-bromo-4-fluorophenyl)-4-morpholin-4-yl-1,2,5-oxadiazole-3-carboximidamide.
Molecular Properties
| Compound Name | N'-(3-bromo-4-fluorophenyl)-4-morpholin-4-yl-1,2,5-oxadiazole-3-carboximidamide |
|---|---|
| PubChem CID | 70642576 |
| Molecular Formula | C13H13BrFN5O2 |
| Molecular Weight | 370.18 g/mol |
| Exact Mass | 369.02 |
| IUPAC Name | N'-(3-bromo-4-fluorophenyl)-4-morpholin-4-yl-1,2,5-oxadiazole-3-carboximidamide |
| SMILES | N/C(=N\c1ccc(F)c(Br)c1)c1nonc1N1CCOCC1 |
| InChI | InChI=1S/C13H13BrFN5O2/c14-9-7-8(1-2-10(9)15)17-12(16)11-13(19-22-18-11)20-3-5-21-6-4-20/h1-2,7H,3-6H2,(H2,16,17) |
| InChIKey | WIKNBDJEIJHBCB-UHFFFAOYSA-N |
| XLogP | 1.84 |
| TPSA | 89.77 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 22 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 370.18 |
| LogP ≤ 5 | 1.84 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 70642576 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.